I am excited to announce two new opportunities to join the MSD Human Health Leadership: the Commercial Strategy and Operations Lead, and the Business Unit Director of Pharmaceuticals, which is a new role. Find out more here: linkedin.com/posts/ben-luca…

Patients are at the centre of what we're about as a company, so I am really grateful to everyone who recently attended our patient hackathon. Find out more about the day here 👇 linkedin.com/posts/ben-luca… #WeAreMSD

Speaking at a Global Counsel report launch event today, Ben Lucas, Managing Director of MSD discussed the upcoming WTO annual meeting which will be a critical opportunity for world leaders to make global trade rules that work better for health products. Read here:

So important for us to play our role in supporting our communities. Thank you MSD for Mothers! #WeAreMSD

Great discussion at the Global Counsel event on lessons from the pandemic and how we can improve global trade rules to benefit patients. This opportunity at next year’s WTO Ministerial Conference must be realised through evidence-led policy-making. linkedin.com/posts/ben-luca…

Last week, we enjoyed hosting the fabulous Jill Nalder as we commemorated #WorldAIDSDay and reflected on the progress that's been made. Thanks for joining us Jill! #WAD23

A really important commitment from NHS to make tangible progress to build from the public health learning of COVID pandemic to protect populations where proven vaccines exist.

This #CervicalCancerPreventionWeek, MSD will be taking the #RacetoElimination to Parliament, celebrating local success towards elimination with MPs and national leaders. Find Out More: msd-uk.com/stories/celebr…

New research from Office of Health Economics reveals that eliminating cervical cancer by 2046 could save the UK £2.6 billion. For more information on how we can harness these savings, read the report here: ohe.org/publications/s…

Our innovative industry is in a great position to be the driver of the health and wealth of the UK. The ABPI's manifesto outlines how the key to achieve this vision is partnership and collaboration, something we at MSD remain focused on/ #WeAreMSD

Parliament was the latest stop on MSD’s Race to Elimination campaign, where we were joined by stakeholders including Victoria Atkins MP, Jess Phillips MP and Jo’s Cervical Cancer Trust to celebrate progress towards eliminating cervical cancer. Stay tuned for our next steps!

As we mark Kidney Cancer Awareness Week, it was a privilege to host Jennifer, a kidney cancer patient, alongside her daughter Rhea and Malcom Packer, the Chief Executive of @KidneyCancerUK. Together we stand united against kidney cancer. #KCAW2024 #WeAreMSD

This report reminds us and policymakers of the need to put the patient voice first in everything we do, so I hope the Patient Advisory Council's insights are a constructive contribution to initiatives to tackle health inequalities and improve standards of care for everyone.

Access to new medicines can help tackle health inequalities. In making decisions on access, we must always listen to the patient voice, as today's report from the Patient Advisory Council shows. Tom Nutt MSD 🟧 Hilary Evans-Newton 🟧 Sarah Woolnough Clare Jacklin Sickle Cell Society Nicola Perrin

We're looking forward to this year's #BTOG 💡 As proud sponsors of the British Thoracic Oncology Group (BTOG), we're excited to engage in critical conversations and explore ways to optimise the lung cancer pathway and ensure high quality of care for patients #BTOG24

We're proud to sponsor #BTOG2024! Acknowledging the entire lung cancer pathway is crucial to ensuring patients receive the best quality of care. We're excited to hear thriving discussions on the ways industry can work together to best support lung cancer patients.

📢 Exciting update! We are proud to extend our partnership agreement with NHS England to eliminate hepatitis C in England. Consistent with our mission to save and improve lives, we look forward to entering what will be the 6th year of this world leading programme

Diving straight into the first session: Implementing the O’ Shaughnessy Review: trials, tribulations and triumphs. Chairing the session Ben Lucas, General Manger UK / Ireland MSD

Yesterday, Patrick Vallance opened our new lab at The Francis Crick Institute in London! We are advancing discovery science with a growing London-based team committed to innovation. Excited to build on MSD’s 100-year heritage in the UK! msd-uk.com/stories/msd-un… Ben Lucas

I'm taking a break from X at the moment, but you can still find me on LinkedIn here: linkedin.com/in/ben-lucas-9…